← Leaderboards
Sarah J Parsons
University Of Virginia Charlottesville
$11,850,077
Attributed
$11,850,077
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2005–10$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$11,850,077 · 8
By mechanism
R01$6,170,449 · 4
T32$4,819,549 · 1
P01$860,079 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Ian G Macara$23,928,271
- Richard J Santen$6,002,791
Others in their field
Top investigators on “Phosphorylation”
- Paul S. Aisen · Cognition Therapeutics, Inc.$88,828,963
- Alan F Horwitz · University Of Virginia Charlottesville$38,916,638
- Tony R. Hunter · Salk Institute For Biological Studies$34,955,666
- Adam L Boxer · Mayo Clinic Rochester$31,930,809
- Keith A. Johnson · Banner Health$30,350,302
- Paul Greengard · Rockefeller University$28,632,392
Research focus
PhosphorylationTissue /Cell CultureBiological Signal TransductionAthymic MouseApoptosisMediatingMalignant NeoplasmsCellsSiteFamily MemberResponseLinkInsightGrowth Factor ReceptorsInhibitor/AntagonistNeoplastic CellLaboratory MouseProtein BindingProtein Tyrosine KinaseEpidermal Growth FactorDesignPlayFamilyBreast Cancer Cell
Grant awards (49)
c-Src/EGF Receptors Interactions and Therapeutic Resistance in Breast Cancer$320,111
R01 · FY2010 · CA · contact PI
c-Src/EGF Receptors Interactions and Therapeutic Resistance in Breast Cancer$313,832
R01 · FY2009 · CA · contact PI
Neuroendocrine Cells in Prostate Cancer$311,012
P01 · FY2009 · CA · contact PI
Cancer Research Training in Molecular Biology$544,335
T32 · FY2008 · CA · contact PI
c-Src/EGF Receptors Interactions and Therapeutic Resistance in Breast Cancer$304,693
R01 · FY2008 · CA · contact PI
The Src Target, p190RhoGAP, in Growth Regulation$290,215
R01 · FY2008 · CA · contact PI
Neuroendocrine Cells in Prostate Cancer$199,617
P01 · FY2008 · CA · contact PI
The Src Target, p190RhoGAP, in Growth Regulation$65,293
R01 · FY2008 · CA · contact PI
Cancer Research Training in Molecular Biology$576,249
T32 · FY2007 · CA · contact PI
The Src Target, p190RhoGAP, in Growth Regulation$304,052
R01 · FY2007 · CA · contact PI
c-Src/EGF Receptors Interactions and Therapeutic Resistance in Breast Cancer$301,675
R01 · FY2007 · CA · contact PI
The Src Target, p190RhoGAP, in Growth Regulation$63,568
R01 · FY2007 · CA · contact PI
Cancer Research Training in Molecular Biology$634,950
T32 · FY2006 · CA · contact PI
c-Src/EGF Receptors Interactions and Therapeutic Resistance in Breast Cancer$314,117
R01 · FY2006 · CA · contact PI
c Src and EGF Receptor in Breast Cancer Development$288,254
R01 · FY2006 · CA · contact PI
The Src Target, p190RhoGAP, in Growth Regulation$266,825
R01 · FY2006 · CA · contact PI
Cancer Research Training in Molecular Biology$39,013
T32 · FY2006 · CA · contact PI
The Src Target, p190RhoGAP, in Growth Regulation$34,799
R01 · FY2006 · CA · contact PI
Cancer Research Training in Molecular Biology$593,223
T32 · FY2005 · CA
Neuroendocrine cells in Prostate Cancer$311,178
R01 · FY2005 · CA
c Src and EGF Receptor in Breast Cancer Development$295,219
R01 · FY2005 · CA
The Src Target, p190RhoGAP, in Growth Regulation$273,061
R01 · FY2005 · CA
Cancer Research Training in Molecular Biology$39,013
T32 · FY2005 · CA
Cancer Research Training in Molecular Biology$601,740
T32 · FY2004 · CA
Neuroendocrine cells in Prostate Cancer$308,402
R01 · FY2004 · CA
c Src and EGF Receptor in Breast Cancer Development$295,275
R01 · FY2004 · CA
The Src Target, p190RhoGAP, in Growth Regulation$272,430
R01 · FY2004 · CA
Cancer Research Training in Molecular Biology$39,013
T32 · FY2004 · CA
c Src and EGF Receptor in Breast Cancer Development$5,607
R01 · FY2004 · CA
Cancer Research Training in Molecular Biology$590,096
T32 · FY2003 · CA
c Src and EGF Receptor in Breast Cancer Development$295,226
R01 · FY2003 · CA
Cancer Research Training in Molecular Biology$38,144
T32 · FY2003 · CA
c Src and EGF Receptor in Breast Cancer Development$3,900
R01 · FY2003 · CA
Cancer Research Training in Molecular Biology$551,819
T32 · FY2002 · CA
c Src and EGF Receptor in Breast Cancer Development$295,302
R01 · FY2002 · CA
Neuroendocrine Cell Signaling in Prostate Cancer$199,030
P01 · FY2002 · CA
Cancer Research Training in Molecular Biology$36,187
T32 · FY2002 · CA
FUNCTION OF C-SRC AND RELATED KINASES IN CHROMAFFIN CELLS$0
P01 · FY2002 · CA
FUNCTION OF C-SRC AND RELATED KINASES IN CHROMAFFIN CELLS$0
P01 · FY2002 · CA
C SRC AND EGF RECEPTOR IN BREAST CANCER DEVELOPMENT$258,987
R01 · FY2001 · CA
SRC FAMILY KINASES AND MITOGENESIS$221,692
R01 · FY2001 · CA
FUNCTION OF C-SRC AND RELATED KINASES IN CHROMAFFIN CELLS$0
P01 · FY2001 · CA
Neuroendocrine Cell Signaling in Prostate Cancer$0
P01 · FY2001 · CA
FUNCTION OF C-SRC AND RELATED KINASES IN CHROMAFFIN CELLS$0
P01 · FY2001 · CA
CANCER RESEARCH TRAINING IN MOLECULAR BIOLOGY$535,767
T32 · FY2000 · CA
C SRC AND EGF RECEPTOR IN BREAST CANCER DEVELOPMENT$251,477
R01 · FY2000 · CA
SRC FAMILY KINASES AND MITOGENESIS$215,259
R01 · FY2000 · CA
Neuroendocrine Cell Signaling in Prostate Cancer$132,463
P01 · FY2000 · CA
FUNCTION OF C-SRC AND RELATED KINASES IN CHROMAFFIN CELLS$17,957
P01 · FY2000 · CA